Developed by the Pediatric Praziquantel Consortium, arpraziquantel reaches the first preschool-aged child in Uganda Arpraziquantel addresses a critical treatment gap for schistosomiasis The Consortium’s work to develop, register, and provide access to arpraziquantel is an important contribution to the elimination of schistosomiasis as a public health problem A preschool-aged girl receives treatment as part of… Read More »First Preschool-Aged Child Receives Arpraziquantel for the Treatment of Schistosomiasis
